114 related articles for article (PubMed ID: 7066193)
21. Distribution of T cell subsets and Langerhans cells in mycosis fungoides, and the effect of PUVA therapy.
Cox NH; Turbitt ML; Ashworth J; Mackie RM
Clin Exp Dermatol; 1986 Nov; 11(6):564-8. PubMed ID: 3499264
[No Abstract] [Full Text] [Related]
22. Treatment of mycosis fungoides with isotretinoin.
Fitzpatrick JE; Mellette JR
J Dermatol Surg Oncol; 1986 Jun; 12(6):626-9. PubMed ID: 3458773
[TBL] [Abstract][Full Text] [Related]
23. Response of mycosis fungoides to topical chemotherapy with mechlorethamine.
Ramsay DL; Parnes RE; Dubin N
Arch Dermatol; 1984 Dec; 120(12):1585-90. PubMed ID: 6508330
[TBL] [Abstract][Full Text] [Related]
24. Contact urticaria and anaphylactoid reaction induced by topical application of nitrogen mustard.
Grunnet E
Br J Dermatol; 1976 Jan; 94(1):101-3. PubMed ID: 1252333
[TBL] [Abstract][Full Text] [Related]
25. Mechlorethamine gel for the topical treatment of stage IA and IB mycosis fungoides-type cutaneous T-cell lymphoma.
Talpur R; Venkatarajan S; Duvic M
Expert Rev Clin Pharmacol; 2014 Sep; 7(5):591-7. PubMed ID: 25068889
[TBL] [Abstract][Full Text] [Related]
26. Nitrogen mustard revisited.
Knobler R
Br J Dermatol; 2014 Mar; 170(3):495. PubMed ID: 24617430
[No Abstract] [Full Text] [Related]
27. Aspects of the treatment of mycosis fungoides. A report from the Scandinavian Mycosis Fungoides Study Group.
Molin L; Thomsen K; Volden G; Groth O; Fischer T; Nordentoft A; Zachariae H
Cutis; 1980 Feb; 25(2):155-7, 160-1. PubMed ID: 6153595
[TBL] [Abstract][Full Text] [Related]
28. Topical mechlorethamine chemotherapy. Considerations on its use in mycosis fungoides.
Vonderheid EC
Int J Dermatol; 1984 Apr; 23(3):180-6. PubMed ID: 6373639
[No Abstract] [Full Text] [Related]
29. Mycosis fungoides. Topical use of nitrogen mustard in recurrent cases.
Arundell FD; Chan WH
Calif Med; 1968 Dec; 109(6):458-61. PubMed ID: 5724878
[TBL] [Abstract][Full Text] [Related]
30. The Stanford University experience with conventional-dose, total skin electron-beam therapy in the treatment of generalized patch or plaque (T2) and tumor (T3) mycosis fungoides.
Navi D; Riaz N; Levin YS; Sullivan NC; Kim YH; Hoppe RT
Arch Dermatol; 2011 May; 147(5):561-7. PubMed ID: 21576575
[TBL] [Abstract][Full Text] [Related]
31. Small malignant melanoma in patients with mycosis fungoides.
Amichai B; Grunwald MH; Goldstein J; Finkelstein E; Halevy S
J Eur Acad Dermatol Venereol; 1998 Sep; 11(2):155-7. PubMed ID: 9784043
[TBL] [Abstract][Full Text] [Related]
32. Granulomatous mycosis fungoides. A 14-year follow-up of a case.
Flaxman BA; Koumans JA; Ackerman AB
Am J Dermatopathol; 1983 Apr; 5(2):145-51. PubMed ID: 6881480
[TBL] [Abstract][Full Text] [Related]
33. [Comparison of the results obtained with ultraviolet radiation and photochemotherapy in the early stages of mycosis fungoides].
Piccinno R; Caccialanza M; Mainardi L
G Ital Dermatol Venereol; 1990 Mar; 125(3):91-5. PubMed ID: 2376422
[TBL] [Abstract][Full Text] [Related]
34. Clinicopathologic features and treatment outcomes in Woringer-Kolopp disease.
Lee J; Viakhireva N; Cesca C; Lee P; Kohler S; Hoppe RT; Kim YH
J Am Acad Dermatol; 2008 Oct; 59(4):706-12. PubMed ID: 18550209
[TBL] [Abstract][Full Text] [Related]
35. Ointment-based mechlorethamine treatment for mycosis fungoides.
Price NM; Hoppe RT; Deneau DG
Cancer; 1983 Dec; 52(12):2214-9. PubMed ID: 6640491
[TBL] [Abstract][Full Text] [Related]
36. [Mycosis fungoides. A form of pleuropulmonary origin with cutaneous sclerodermiform manifestations. Treatment by application of nitrogen mustard].
Gueguen MH
Bull Soc Fr Dermatol Syphiligr; 1971; 78(6):617-8. PubMed ID: 5161189
[No Abstract] [Full Text] [Related]
37. Long-term topical nitrogen mustard treatment does not induce pulmonary fibrosis in MF patients.
Nielsen M; Rasmussen K; Knudsen N; Thestrup-Pedersen K
Acta Derm Venereol; 1994 Jan; 74(1):70-1. PubMed ID: 7908491
[TBL] [Abstract][Full Text] [Related]
38. Complete remissions of mycosis fungoides lymphoma induced by topical nitrogen mustard (HN2). Control of delayed hypersensitivity to HN2 by desensitization and by induction of specific immunologic tolerance.
Van Scott EJ; Kalmanson JD
Cancer; 1973 Jul; 32(1):18-30. PubMed ID: 4577503
[No Abstract] [Full Text] [Related]
39. The treatment of mycosis fungoides with ointment-based mechlorethamine.
Price NM; Deneau DG; Hoppe RT
Arch Dermatol; 1982 Apr; 118(4):234-7. PubMed ID: 7065680
[TBL] [Abstract][Full Text] [Related]
40. PUVA-induced suppression of contact sensitivity to mustine hydrochloride in mycosis fungoides.
Volden G; Molin L; Thomsen K
Br Med J; 1978 Sep; 2(6141):865-6. PubMed ID: 152137
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
